Books > Science & Mathematics > Biology, life sciences
|
Buy Now
Managed Entry Agreements and Funding for Expensive Therapies (Hardcover)
Loot Price: R4,020
Discovery Miles 40 200
|
|
Managed Entry Agreements and Funding for Expensive Therapies (Hardcover)
Series: Pharmaceuticals, Health Economics and Market Access
Expected to ship within 12 - 17 working days
|
Market entry agreements (MEA) for pharmaceuticals have become
extremely popular and widespread geographically. Emerging countries
that have not yet begun to introduce MEAs are now actively engaged
in doing so. This book examines the concept of MEAs, detailing how
depreciation of some specific regenerative therapies through
intangible asset amortization is unavoidable. The authors provide a
historical vision of the development of MEAs with experiences,
failures, and successes that have shaped the evolution and place of
MEAs in access to pharmaceuticals. They provide an extensive review
of MEA typology and propose a new one that is pragmatic and
actionable. FEATURES Discusses the affordability of future
therapies and the possible challenges for health insurance systems
Addresses the practical and applied issue of market access and
includes the most up-to-date developments, such as the Pelosi bill
Describes the potential paradigm change that will challenge all
payers and may question the sustainability of our health care
systems Highlights the gradual move from repeated treatment
administration to a single administration with the potential for a
definite cure Managed Entry Agreements and Funding for Expensive
Therapies provides invaluable information to all stakeholders
involved in market access and to students in the field.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.